FLIPS: Ferfer Liposomal Iron Performance Study

• Status: Completed
• Trial end date: 2019-01-31
• Target enrollment: 0
• Participant gender: Female

Summary

To evaluate the efficacy of a novel food supplement, Ferfer® to raise the capacity of Haemoglobin and Haematocrit levels

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: PharmEvo Pvt Ltd
• Treatments: Iron

Criteria

Inclusion Criteria:

• Iron deficiency anemia (Hemoglobin <8 to >5 g/dl)

• Subjects able to provide written informed consent;

• Subjects already treated with other iron supplements or drugs that experienced side effects (not including allergy) related to iron administration.

• Wash out period will be a week

Exclusion Criteria:

• Had a history of iron intolerance

• Hypersensitivity and allergic of Vit C and Vit B12

• Not willing to take informed consent